Sökresultat - "Early Breast Cancer Trialists' Collaborative Group"

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

Early Breast Cancer Trialists Collaborative Group (EBCTCG)

Malmström, Per, Creator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer-genetics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer-genetik, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Tumor microenvironment, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Tumörmikromiljö, Originator

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials

Taylor, Carolyn, Correa, Candace, Duane, Frances K, Aznar, Marianne C, Anderson, Stewart J, Bergh, Jonas, Dodwell, David, Ewertz, Marianne, Gray, Richard, Jagsi, Reshma, Pierce, Lori, Pritchard, Kathleen I, Swain, Sandra, Wang, Zhe, Wang, Yaochen, Whelan, Tim, Peto, Richard, McGale, Paul, Early Breast Cancer Trialists’ Collaborative Group

Malmström, Per, Creator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer-genetics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer-genetik, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Tumor microenvironment, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Tumörmikromiljö, Originator

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials

Early Breast Cancer Trialists Collaborative Group (EBCTCG)

Malmström, Per, Creator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Tumor microenvironment, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Tumörmikromiljö, Originator

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

Early Breast Cancer Trialists Collaborative Group (EBCTCG)

Malmström, Per, Creator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Tumor microenvironment, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Tumörmikromiljö, Originator

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

EBCTCG (Early Breast Cancer Trialists' Collaborative Group)

Malmström, Per, Creator, Lund University, Faculty of Medicine, Lunds universitet, Medicinska fakulteten, Originator

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

Early Breast Cancer Trialists Collaborative Group (EBCTCG)

Malmström, Per, Creator, Lund University, Faculty of Medicine, Lunds universitet, Medicinska fakulteten, Originator

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

Early Breast Cancer Trialists Collaborative Group (EBCTCG), Darby, S, McGale, P, Correa, C, Taylor, C, Arriagada, R, Clarke, M, Cutter, D, Davies, C, Ewertz, M, Godwin, J, Gray, R, Pierce, L, Whelan, T, Wang, Y, Peto, R

Malmström, Per, Creator, Lund University, Faculty of Medicine, Lunds universitet, Medicinska fakulteten, Originator

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

Early Breast Cancer Trialists Collaborative Group (EBCTCG)

Malmström, Per, Creator, Lund University, Faculty of Medicine, Lunds universitet, Medicinska fakulteten, Originator

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.

Early, Breast Cancer Trialists' Collaborative Group (EBCTCG), Correa, C, McGale, P, Taylor, C, Wang, Y, Clarke, M, Davies, C, Peto, R, Bijker, N, Solin, L

Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials

Clarke, M, Coates, A S, Darby, S C, Davies, C, Gelber, R D, Godwin, J, Goldhirsch, A, Gray, R, Peto, R, Pritchard, K I, Wood, W C, Early Breast Cancer Trialists Collaborative Group (EBCTCG)

Malmström, Per, Creator, Lund University, Faculty of Medicine, Lunds universitet, Medicinska fakulteten, Originator

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

Early Breast Cancer Trialists Collaborative Group (EBCTCG)

Malmström, Per, Creator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Originator

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (CORPORATE AUTHOR)

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.

Early Breast Cancer Trialists’ Collaborative group (EBCTCG) (CORPORATE AUTHOR)

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

Early Breast Cancer Trialists' Collaborative Group (CORPORATE AUTHOR)

Tamoxifen for early breast cancer: an overview of the randomised trials.

Early Breast Cancer Trialists' Collaborative Group (CORPORATE AUTHOR)

Ovarian ablation in early breast cancer: overview of the randomised trials... including commentary by Barley V.

Early Breast Cancer Trialists' Collaborative Group (CORPORATE AUTHOR)

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (CORPORATE AUTHOR)

Postmastectomy radiotherapy in patients with breast cancer – Authors' reply

Early Breast Cancer Trialists' Collaborative Group

Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials.

Early Breast Cancer Trialists' Collaborative Group (CORPORATE AUTHOR)

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women

EARLY BREAST CANCER TRIALISTS' COLLABORATIVE GROUP